American media: Monkey acne virus has been evolving and mutating, doctors should be alert to drug resistance

Jimu Journalist Li Manying

According to the Associated Press reported on September 16, US health officials warned that they reminded doctors that do not over -use a single medicine that can be used to treat monkey acne during treatment. Because monkey acne virus has been evolving, it may have been resistant to this.

Vaccine vaccination scene (picture source: "Washington Post")

Monkey acne virus may have drug resistance

According to the Associated Press, this week, the US Food and Drug Administration has updated the guidelines for the treatment of acne treatment. At present, doctors have issued prescriptions to tens of thousands of patients infected with monkey acne.

The US Food and Drug Administration reminds that in order to overcome the disorders including drugs, monkey acne virus has been evolving and mutating. TPOXX, currently used to treat monkey acne, is aimed at monkey acne, smallpox and virus -like antiviral drugs. The results of laboratories, animals and humans show that monkey acne may produce resistance to this treatment in many ways. Essence Therefore, doctors need to be more cautious.

Dr. Anthony Fitch, the highest infectious disease official in the United States, also said that drug resistance is always a risk when using antiviral drugs.

"That's why you feel uncomfortable when you use only one drug." Fudi told reporters. He added that a TPOXX study supported by the National Institute of Health will track signs of mutations that may lead to drug resistance, which is expected to recruit more than 500 patients in 60 locations in the United States.

The decline in the American monkey acne cases

What is gratifying is that according to the Washington Post, local time on Thursday, federal officials expressed optimism on the development of the epidemic of monkey acne on Thursday, and pointed out that since the peak of new cases reached the peak in August, it has fallen by about 50%. Essence

At the White House briefing, Dr. Rosel Valencesky, Director of the Centers for Disease Control and Control Center, attributed this decline to vaccination, health mission, and national individuals related to dissemination. Although officials emphasize that the virus can infect anyone, most American cases occur in male and male actors.

Local time this Thursday, the US Centers for Disease Control and Prevention requires that TPOXX should only be used to treat patients with severe illnesses. "For most patients with health systems, supporting and pain control may be enough." The institution officials said in a statement.

TPOXX is approved to treat ceiling viruses. It is considered experimental and strictly controlled by federal officials.

The American Center for Disease Control and Prevention hopes that the doctor who prescribes the drug must submit an application to the patient's needs and agree to track their results and any side effects.

At present, officials have transported drugs to doctors with 37,000 courses.

- END -